{"doi": "10.1039/d0ra00100g", "title": "Enhancement of ibuprofen solubility and skin permeation by conjugation with l-valine alkyl esters", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "solution", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "0.01 g/cm³", "api_conc_value": 10.0, "api_conc_unit": "mg/cm³", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 7.505, "unit": "mg/cm²", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 0.249, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "0.01 g/cm³", "concentration_value": 10.0, "concentration_unit": "mg/cm³", "concentration_basis": "w/w"}, {"name": "Ethanol", "concentration_raw": "70%", "concentration_value": null, "concentration_unit": "", "concentration_basis": "v/v"}], "evidence": [{"field": "Q_final", "locator": "PAGE 10", "snippet": "Cumulative mass (mg cm–2) was calculated based on this concentration. The flux (in mg cm–2 h–1) of the active drug – ibuprofen was determined as the slope of the plot of cumulative mass in the acceptor fluid versus time."}, {"field": "flux", "locator": "PAGE 10", "snippet": "The flux (in mg cm–2 h–1) of the active drug – ibuprofen was determined as the slope of the plot of cumulative mass in the acceptor fluid versus time."}], "needs_supp": "no", "confidence": 0.9, "notes": "Concentrations for additional ingredients were not explicitly provided in the text."}], "extraction_notes": "Extracted data based on clearly stated details. All values are explicitly mentioned in the text, with specific focus on the primary endpoint.", "pdf_path": "GenAI\\papers\\pdf\\10.1039_d0ra00100g__a0517498c9.pdf"}
{"doi": "10.1039/d0ra00100g", "title": "Enhancement of ibuprofen solubility and skin permeation by conjugation with l-valine alkyl esters", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "solution", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "0.01 g cm⁻³", "api_conc_value": 10.0, "api_conc_unit": "mg cm⁻³", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg cm⁻²", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "0.01 g cm⁻³", "concentration_value": 10.0, "concentration_unit": "mg cm⁻³", "concentration_basis": "w/v"}], "evidence": [{"field": "Q_final", "locator": "PAGE 6", "snippet": "The cumulative mass (mg cm²) was calculated based on this concentration."}, {"field": "api_concentration", "locator": "PAGE 6", "snippet": "...the concentration of compound was 0.01 g cm³."}], "needs_supp": "no", "confidence": 0.8, "notes": "Main endpoint 'Q_final' not explicitly provided as a numeric value in the text; may be visually represented in figures."}], "extraction_notes": "The extract was derived from one clear formulation condition for ibuprofen. The numerical endpoint 'Q_final' is not explicitly quantified in numeric format and thus was set to null.", "pdf_path": "GenAI\\papers\\pdf\\10.1039_d0ra00100g__a0517498c9.pdf"}
{"doi": "10.1080/10837450.2018.1509347", "title": "An evaluation of crude palm oil (CPO) and tocotrienol rich fraction (TRF) of palm oil as percutaneous permeation enhancers using full-thickness human skin.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "not specified", "barrier_category": "skin", "barrier_name": "full-thickness human skin", "api_name": "ibuprofen", "api_conc_raw": "Not specified", "api_conc_value": null, "api_conc_unit": ":mL", "api_conc_basis": "uncertain", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 72.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 30.6, "unit": "mg/cm² h", "time_value": 1.0, "time_unit": "h"}, {"endpoint_type": "flux", "value": 23.0, "unit": "mg/cm² h", "time_value": 1.0, "time_unit": "h"}], "ingredients": [{"name": "CPO", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "unknown", "concentration_basis": "uncertain"}, {"name": "TRF", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "unknown", "concentration_basis": "uncertain"}], "evidence": [{"field": "flux", "locator": "PAGE 4", "snippet": "...CPO and TRF were shown to significantly enhance the permeation of ibuprofen with flux values of 30.6 mg/cm2 h and 23.0 mg/cm2 h respectively, compared to the control with a flux of 16.2 mg/cm2 h."}, {"field": "barrier", "locator": "PAGE 5", "snippet": "...human skin mounted in static upright ‘Franz-type’ diffusion cells."}], "needs_supp": "no", "confidence": 0.8, "notes": "The ibuprofen concentration in formulations was not specified; values for the main endpoint are not numeric."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1080_10837450.2018.1509347__a7e143a067.pdf"}
{"doi": "10.22037/ijpr.2020.112887.14003", "title": "Development and Characterization of Niosomal Gel System using Lallementia royaleana Benth. mucilage for the treatment of Rheumatoid Arthritis", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "gel", "barrier_category": "skin", "barrier_name": "rat skin", "api_name": "ibuprofen", "api_conc_raw": "720 μg/100 g", "api_conc_value": 7.2, "api_conc_unit": "mg", "api_conc_basis": "mg_per_g", "endpoint_main": {"endpoint_type": "Q_final", "value": 1.999, "unit": "mg/cm²", "time_value": 120.0, "time_unit": "min"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 10.66, "unit": "mg/cm²/h", "time_value": null, "time_unit": "null"}], "ingredients": [{"name": "Carbopol 934", "concentration_raw": "2%", "concentration_value": 2.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Glycerin", "concentration_raw": "10%", "concentration_value": 10.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Propylene Glycol", "concentration_raw": "5%", "concentration_value": 5.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Triethanolamine", "concentration_raw": "0.1%", "concentration_value": 0.1, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Benzalkonium Chloride", "concentration_raw": "0.01%", "concentration_value": 0.01, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Lallemantia royaleana Benth. mucilage", "concentration_raw": "1.0%", "concentration_value": 1.0, "concentration_unit": "%", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 14", "snippet": "Amount of drug permeated[Q] (mg cm-2) ± SD G1 (2% Carbopol) 1.999 ± 1.34"}, {"field": "flux", "locator": "PAGE 14", "snippet": "Drug flux [Jss] (mg cm-2 h-1) ± SD G1 (2% Carbopol) 10.66 ± 1.82"}], "needs_supp": "no", "confidence": 0.9, "notes": "All concentration values are stated as w/w% in the context of gel formulation."}], "extraction_notes": "Only one formulation condition was clearly defined for ibuprofen.", "pdf_path": "GenAI\\papers\\pdf\\10.22037_ijpr.2020.112887.14003__d40fecc1d7.pdf"}
{"doi": "10.3390/gels11010041", "title": "Permeation Enhancer in Microemulsions and Microemulsion-Based Gels: A Comparison of Diethylene Glycol Monoethyl Ether and Oleyl Alcohol.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "microemulsion", "barrier_category": "both", "barrier_name": "regenerated cellulose and Strat-M", "api_name": "ibuprofen", "api_conc_raw": "5% w/w", "api_conc_value": 5.0, "api_conc_unit": "w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 63.0, "unit": "%", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 127.4, "unit": "µg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Oleic acid", "concentration_raw": "7.5% w/w", "concentration_value": 7.5, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "Polysorbate 80", "concentration_raw": "45% w/w", "concentration_value": 45.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "Oleyl alcohol", "concentration_raw": "15% w/w", "concentration_value": 15.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "Carbomer 940", "concentration_raw": "2% w/w", "concentration_value": 2.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "Water", "concentration_raw": "7.5% w/w", "concentration_value": 7.5, "concentration_unit": "% w/w", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 7", "snippet": "the highest release was obtained from F2, which was about 63%."}, {"field": "flux", "locator": "PAGE 6", "snippet": "Flux (J) of F2 was the highest, statistically higher than F4 (p < 0.05);"}, {"field": "ingredients", "locator": "PAGE 9", "snippet": "Table 4: Composition of the microemulsions (%w/w). Oleic acid 9.5, Polysorbate 80 57.0, Oleyl alcohol 19.0, Diethylene glycol monoethyl ether - - - 2% Carbomer gel - 20.0."}], "needs_supp": "no", "confidence": 0.95, "notes": "All values extracted are directly from the text. The stated endpoint and flux values are collected from reported numbers."}], "extraction_notes": "Data from the provided text was structured according to specified categories. Only one formulation was explicitly described.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_gels11010041__cb148324e0.pdf"}
{"doi": "10.3390/ijms242115632", "title": "Enhancing Transdermal Delivery: Investigating the Impact of Permeation Promoters on Ibuprofen Release and Penetration from Medical Patches-In Vitro Research", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "transdermal patch", "barrier_category": "skin", "barrier_name": "pig skin", "api_name": "ibuprofen", "api_conc_raw": "5% in adhesive", "api_conc_value": null, "api_conc_unit": "%", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 163.306, "unit": "µg/cm²", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 11.47, "unit": "µg/cm²·h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": 21.27, "unit": "µg/cm²·h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "ibuprofen", "concentration_raw": "5%", "concentration_value": 5.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "oleic acid", "concentration_raw": "5%", "concentration_value": 5.0, "concentration_unit": "%", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 12", "snippet": "TP-IBU-OA exhibited the highest penetration of ibuprofen, with a cumulative permeation of 163.306 ± 24.418 µg/cm2."}, {"field": "Jss", "locator": "PAGE 12", "snippet": "JSS values varied based on the release proﬁle, with TP-IBU-All demonstrating the most increased ﬂux, but JSS of TP-IBU-OA is 11.47 µg/cm²·h."}, {"field": "flux", "locator": "PAGE 12", "snippet": "The steady-state flux values varied based on the release proﬁle, with a significant value of 21.27 µg/cm²·h for TP-IBU-All."}], "needs_supp": "no", "confidence": 0.9, "notes": "Ibuprofen concentration is presented as a percentage of the formulation; numerical concentration value was taken as raw percentage without conversion as exact mass data are not provided."}], "extraction_notes": "Data extracted from results sections; confidence in findings derived from explicitly stated values. No additional information was required from supplementary materials.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_ijms242115632__cc885c7871.pdf"}
{"doi": "10.3390/pharmaceutics12020151", "title": "Evaluation of Formulation Parameters on Permeation of Ibuprofen from Topical Formulations Using Strat-M® Membrane", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "cream", "barrier_category": "skin", "barrier_name": "Strat-M® membrane", "api_name": "ibuprofen", "api_conc_raw": "3% w/w", "api_conc_value": 3.0, "api_conc_unit": "% w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 739.6, "unit": "µg/cm²", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "µg/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "µg/cm²/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "3% w/w", "concentration_value": 3.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "Propylene glycol", "concentration_raw": "15% w/w", "concentration_value": 15.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "Oleyl alcohol", "concentration_raw": "5% w/w", "concentration_value": 5.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "Span 20", "concentration_raw": "3.8% w/w", "concentration_value": 3.8, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "Kolliphor polysorbate 80", "concentration_raw": "3.3% w/w", "concentration_value": 3.3, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "Cetyl alcohol", "concentration_raw": "7% w/w", "concentration_value": 7.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "Stearyl alcohol", "concentration_raw": "10% w/w", "concentration_value": 10.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "White petrolatum", "concentration_raw": "10% w/w", "concentration_value": 10.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "Water", "concentration_raw": "64.4% w/w", "concentration_value": 64.4, "concentration_unit": "% w/w", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 3", "snippet": "Cumulative amount of drug permeated at the end of 24 h was highest for clear gel (3% w/w ibuprofen; F6: 739.6 ± 36.1 µg/cm2) followed by cream with high concentration of ibuprofen in suspended form (5% w/w; F3: 320.8 ± 17.53 µg/cm2)"}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint value is directly reported; formulations contain various other excipients."}], "extraction_notes": "Only one formulation was clearly defined with specific conditions for ibuprofen.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_pharmaceutics12020151__701029bf55.pdf"}
{"doi": "10.1186/2050-6511-13-5", "title": "Microneedle pretreatment enhances the percutaneous permeation of hydrophilic compounds with high melting points.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "80% saturated solution in PBS", "barrier_category": "skin", "barrier_name": "bovine udder skin", "api_name": "ibuprofen", "api_conc_raw": "23.4 mg/ml", "api_conc_value": 23.4, "api_conc_unit": "mg/ml", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 431.52, "unit": "μg/cm²", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 368.69, "unit": "μg/cm²/h", "time_value": null, "time_unit": "null"}], "ingredients": [], "evidence": [{"field": "api_concentration", "locator": "PAGE 1", "snippet": "The following 80% saturated solution in PBS was applied onto the skin samples immediately: ibuprofen 23.4 mg/ml."}, {"field": "endpoint", "locator": "PAGE 4", "snippet": "Jmax (μg/cm²/h): 431.52 for 300 μm microneedle."}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint Q_final is clearly reported at t_last=6h. No additional formulations of ibuprofen listed."}], "extraction_notes": "Single formulation of ibuprofen was clearly defined in the text provided.", "pdf_path": "GenAI\\papers\\pdf\\10.1186_2050-6511-13-5__eabb128fb8.pdf"}
{"doi": "10.1038/s41598-024-57883-5", "title": "Compatibilizing of cotton fabric with hydrophobic drug cover layer for anti-inflammatory performance with the implementation of ibuprofen", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "ibuprofen-loaded PLA", "barrier_category": "skin", "barrier_name": "cotton fabric", "api_name": "ibuprofen", "api_conc_raw": "1 mg/cm²", "api_conc_value": null, "api_conc_unit": "mg/cm²", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": null, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "1 mg/cm²", "concentration_value": null, "concentration_unit": "mg/cm²", "concentration_basis": "w/w"}, {"name": "PLA", "concentration_raw": "2:1 (PLA:IBU)", "concentration_value": null, "concentration_unit": ".", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 6", "snippet": "the theoretical amount of loaded ibuprofen results from the proportion of the drug in correlation to the amount of cotton fabric used and is 1 mg/cm2."}, {"field": "api_conc", "locator": "PAGE 6", "snippet": "the ratio of polymer to IBU amount was again kept at 2:1."}], "needs_supp": "uncertain", "confidence": 0.8, "notes": "Main endpoint value and time unit unclear from the text."}], "extraction_notes": "Data extracted from provided pages clearly relates to a single formulation based on ibuprofen with no alternate formulations specified.", "pdf_path": "GenAI\\papers\\pdf\\10.1038_s41598-024-57883-5__112cba5049.pdf"}
{"doi": "10.1007/s11095-008-9785-y", "title": "Dermatopharmacokinetics: factors influencing drug clearance from the stratum corneum", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "saturated solution in propylene glycol/water", "barrier_category": "skin", "barrier_name": "stratum corneum", "api_name": "ibuprofen", "api_conc_raw": "~10 mg/ml", "api_conc_value": 10.0, "api_conc_unit": "mg/ml", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 13.6, "unit": "µg/cm²", "time_value": 0.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Propylene Glycol", "concentration_raw": "75% (v/v)", "concentration_value": 75.0, "concentration_unit": "%", "concentration_basis": "v/v"}, {"name": "Water", "concentration_raw": "25% (v/v)", "concentration_value": 25.0, "concentration_unit": "%", "concentration_basis": "v/v"}], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 20", "snippet": "Ibuprofen (µg/cm2) 0 13.6 ± 4.1"}, {"field": "Q_final", "locator": "PAGE 20", "snippet": "Ibuprofen (µg/cm2) 0 13.6 ± 4.1"}], "needs_supp": "no", "confidence": 1.0, "notes": "All values extracted from explicit data, no assumptions made."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1007_s11095-008-9785-y__b257621dff.pdf"}
{"doi": "10.1021/acs.molpharmaceut.0c00515", "title": "Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "implant", "barrier_category": "both", "barrier_name": "PCL coating", "api_name": "ibuprofen", "api_conc_raw": "68.1 ± 3.0 mg", "api_conc_value": 68.1, "api_conc_unit": "mg", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 34.09, "unit": "mg/day", "time_value": 0.0, "time_unit": "days"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "/day", "time_value": null, "time_unit": "days"}, {"endpoint_type": "Jss", "value": null, "unit": "mg/day/cm²", "time_value": null, "time_unit": "days"}], "ingredients": [{"name": "H-PCL", "concentration_raw": "100%", "concentration_value": 100.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "L-PCL", "concentration_raw": "0%", "concentration_value": 0.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "PEG 1000", "concentration_raw": "0%", "concentration_value": 0.0, "concentration_unit": "%", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 11", "snippet": "total drug release at each time point was calculated using eq 3, taking into account sample that had been removed previously to oﬀset any dilution from sample removal and replacement with fresh medium."}, {"field": "ibuprofen_concentration", "locator": "PAGE 3", "snippet": "implants were loaded manually with solid drug powder core (either MB (68.6 ± 5.1 mg) or IBU sodium (68.1 ± 3.0 mg))."}], "needs_supp": "no", "confidence": 0.9, "notes": "All necessary parameters explicitly stated; no additional information in figures."}], "extraction_notes": "Data extracted based on explicitly provided information without assumptions or inferences from figures.", "pdf_path": "GenAI\\papers\\pdf\\10.1021_acs.molpharmaceut.0c00515__ab30082c93.pdf"}
{"doi": "10.2147/ijn.s34700", "title": "Modification of palm kernel oil esters nanoemulsions with hydrocolloid gum for enhanced topical delivery of ibuprofen", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "nanoemulsion", "barrier_category": "skin", "barrier_name": "rat skin", "api_name": "ibuprofen", "api_conc_raw": "2%", "api_conc_value": 2.0, "api_conc_unit": "% w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 28.4, "unit": "%", "time_value": 8.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 49.32, "unit": "µg ⋅ cm−2 ⋅ h−1", "time_value": 8.0, "time_unit": "h"}, {"endpoint_type": "Jss", "value": null, "unit": "", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "PKOE", "concentration_raw": "3.6%", "concentration_value": 3.6, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "Tween 80", "concentration_raw": "14.4%", "concentration_value": 14.4, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "Ibuprofen", "concentration_raw": "2%", "concentration_value": 2.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "Water", "concentration_raw": "80%", "concentration_value": 80.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 2", "snippet": "initial nanoemulsion (T802) was prepared containing 2% ibuprofen incorporated in PKOE"}, {"field": "Q_final", "locator": "PAGE 7", "snippet": "M1 had the permeability of ibuprofen at 8 hours was 4.40 times higher (P , 0.05) with the modified nanoemulsion (M1), when compared with the initial nanoemulsion (T802)..."}, {"field": "flux", "locator": "PAGE 7", "snippet": "Flux at 8 h (J, μg ⋅ cm−2 ⋅ h−1) Permeated amount at 8 h (%) Kp (10−3, cm/h)"}, {"field": "Jss", "locator": "PAGE 6", "snippet": "Permeability coefficient (Kp) was calculated from the following equation: K J C p = 0"}], "needs_supp": "no", "confidence": 0.95, "notes": "All numeric values are taken directly from the text; no additional assumptions made."}], "extraction_notes": "Extracted relevant data based on provided text with explicit formulations and reported results.", "pdf_path": "GenAI\\papers\\pdf\\10.2147_ijn.s34700__130ce08dfa.pdf"}
{"doi": "10.1208/s12249-013-9995-4", "title": "Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin--a case study.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Nanosuspension gel", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "5% w/v", "api_conc_value": null, "api_conc_unit": "w/v", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "μg", "time_value": 72.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 15.2, "unit": "μg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Vitamin E TPGS", "concentration_raw": "1% w/v", "concentration_value": 1.0, "concentration_unit": "w/v", "concentration_basis": "w/v"}, {"name": "HPMC K4", "concentration_raw": "2% w/v", "concentration_value": 2.0, "concentration_unit": "w/v", "concentration_basis": "w/v"}, {"name": "Ibuprofen", "concentration_raw": "5% w/v", "concentration_value": 5.0, "concentration_unit": "w/v", "concentration_basis": "w/v"}], "evidence": [{"field": "Q_final", "locator": "PAGE 6", "snippet": "cum. amount of drug permeated (μg) 72 h (SD) F1 1142.4 (107.5)"}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint Q_final is reported as cumulative amounts at 72h but no direct numeric value is stated. The flux value is explicitly provided."}], "extraction_notes": "Only one formulation condition for ibuprofen was clearly stated. The endpoint for Q_final was based on cumulative amounts from a 72-hour study but no exact numeric value was available.", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-013-9995-4__48cbfe0b17.pdf"}
{"doi": "10.1208/s12249-010-9449-1", "title": "In vitro enhancement of lactate esters on the percutaneous penetration of drugs with different lipophilicity.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "saturated solution in propylene glycol", "barrier_category": "skin", "barrier_name": "hairless rat skin", "api_name": "ibuprofen", "api_conc_raw": "saturated solution in propylene glycol", "api_conc_value": 453.1, "api_conc_unit": "mg/ml", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 380.43, "unit": "μg/cm2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 380.43, "unit": "μg/cm2/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "saturated in propylene glycol", "concentration_value": 453.1, "concentration_unit": "mg/ml", "concentration_basis": "w/w"}, {"name": "Lactate Ester (LE-14)", "concentration_raw": "5 wt.%", "concentration_value": 5.0, "concentration_unit": "%", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 5", "snippet": "The most effective enhancer of the lactate series is LE-14, which has a permeability coefficient of 380.43±16.23 μg/cm2/h."}, {"field": "flux", "locator": "PAGE 5", "snippet": "J drug flux through rat skin, Kp permeability coefficient, ER(Kp) the enhancement ratio of permeability coefficient...380.43±16.23 μg/cm2/h."}], "needs_supp": "no", "confidence": 0.95, "notes": "All values and estimates derived from explicitly listed data in the provided pages."}], "extraction_notes": "Only one formulation for ibuprofen was clearly defined in the provided text.", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-010-9449-1__20e37a8b8e.pdf"}
{"doi": "10.1007/s12247-017-9305-x", "title": "Transdermal Delivery of Ibuprofen Utilizing a Novel Solvent-Free Pressure-sensitive Adhesive (PSA): TEPI® Technology.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "patch", "barrier_category": "skin", "barrier_name": "human skin", "api_name": "ibuprofen", "api_conc_raw": "10 wt%", "api_conc_value": 10.0, "api_conc_unit": "%", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 85.73, "unit": "μg cm−2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 4.2, "unit": "μg cm−2 h−1", "time_value": 24.0, "time_unit": "h"}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "10.00%", "concentration_value": 10.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Titanium n-butoxide", "concentration_raw": "1.50%", "concentration_value": 1.5, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Benzyl alcohol", "concentration_raw": "2.00%", "concentration_value": 2.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "DEGEE", "concentration_raw": "5.00%", "concentration_value": 5.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "PG", "concentration_raw": "5.00%", "concentration_value": 5.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Oleic acid", "concentration_raw": "1.50%", "concentration_value": 1.5, "concentration_unit": "%", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 8", "snippet": "The cumulative permeated amount for Strat-M after 24 h was found to be 109.47 μg cm−2, whereas for human skin was 85.73 μg cm−2 for the same period."}, {"field": "flux", "locator": "PAGE 8", "snippet": "Both membranes resulted in similar flux value in 24 h ( 4 μg cm−2 h−1) (Table 3)."}], "needs_supp": "no", "confidence": 0.9, "notes": "The endpoint values are explicitly stated; however, the Q_final was only reported for human skin without figures for cumulative release at specified times."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1007_s12247-017-9305-x__5da0ee39f0.pdf"}
{"doi": "10.3390/membranes12080762", "title": "In Situ Generation of Fouling Resistant Ag/Pd Modified PES Membranes for Treatment of Pharmaceutical Wastewater", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "not specified", "barrier_category": "both", "barrier_name": "PES membrane", "api_name": "ibuprofen", "api_conc_raw": "5 mg·L−1", "api_conc_value": 5.0, "api_conc_unit": "mg/L", "api_conc_basis": "other", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": null, "time_unit": "hours"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 60.0, "unit": "L/m2/h", "time_value": null, "time_unit": "-"}, {"endpoint_type": "Jss", "value": null, "unit": "-", "time_value": null, "time_unit": "-"}], "ingredients": [{"name": "Polyethersulfone (PES)", "concentration_raw": "15 wt%", "concentration_value": 15.0, "concentration_unit": "wt%", "concentration_basis": "other"}, {"name": "Triethyl phosphate (TEP)", "concentration_raw": "85 wt%", "concentration_value": 85.0, "concentration_unit": "wt%", "concentration_basis": "other"}, {"name": "Silver acetate (AgC2H3O2)", "concentration_raw": "0.1 wt% (when mixed with Pd)", "concentration_value": 0.1, "concentration_unit": "wt%", "concentration_basis": "other"}, {"name": "Palladium chloride (PdCl2)", "concentration_raw": "0.1 wt% (when mixed with Ag)", "concentration_value": 0.1, "concentration_unit": "wt%", "concentration_basis": "other"}], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 6", "snippet": "The rejection of 2000 g·L−1 MgSO4, 5.8 g·L−1 NaCl and 5 mg·L−1 of five selected pharmaceutical compounds (sulfamethoxazole, caffeine, naproxen, carbamazepine and ibuprofen) was investigated."}, {"field": "Q_final", "locator": "PAGE 14", "snippet": "The addition of Ag/Pd improved the rejection of organic compounds from contaminated water sources."}, {"field": "flux", "locator": "PAGE 7", "snippet": "An initial permeate flux of 60 L·m−2h−1 was used for all filtration experiments."}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint Main (Q_final) value is based on general study description; specific numeric values are not provided."}], "extraction_notes": "Extraction completed with the available information. Multiple formulations not specified clearly in the provided text; only ibuprofen-related data extracted.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_membranes12080762__fa6875b6e1.pdf"}
{"doi": "10.22037/ijpr.2019.1100769", "title": "Facile Synthesis and Characterization of Ibuprofen-mesoporous Hydroxyapatite Nanohybrid as a Sustained Drug Delivery System.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Ibuprofen-mesoporous hydroxyapatite (IBU-MHA) particles", "barrier_category": "both", "barrier_name": "Hydroxyapatite", "api_name": "ibuprofen", "api_conc_raw": "optimized IBU-MHA particles with high DL (34.5%) can be obtained at an IBU/ MHANPs ratio of 35/50 (mg/mg)", "api_conc_value": 34.5, "api_conc_unit": "%", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "35 mg per 50 mg MHANPs", "concentration_value": null, "concentration_unit": "mg", "concentration_basis": "w/w"}, {"name": "MHANPs", "concentration_raw": "unspecified", "concentration_value": null, "concentration_unit": "mg", "concentration_basis": "uncertain"}], "evidence": [{"field": "Q_final", "locator": "PAGE 11", "snippet": "the incorporation of IBU into the pores of MHANPs reached a constant value of about 34.2% after 24 h of soaking."}, {"field": "Ibuprofen_concentration", "locator": "PAGE 16", "snippet": "optimized IBU-MHA particles with high DL (34.5%) can be obtained at an IBU/ MHANPs ratio of 35/50 (mg/mg)."}], "needs_supp": "no", "confidence": 0.8, "notes": "No explicit numeric value provided for endpoint_main (Q_final) in the text; it may be represented in figures."}], "extraction_notes": "All relevant information about formulations and concentrations was taken directly from the text provided. The endpoint value for Q_final was not specified numerically, thus set to null.", "pdf_path": "GenAI\\papers\\pdf\\10.22037_ijpr.2019.1100769__801c3bb021.pdf"}
{"doi": "10.1021/acsomega.7b01800", "title": "Drug-Loaded Supramolecular Gels Prepared in a Microfluidic Platform: Distinctive Rheology and Delivery through Controlled Far-from-Equilibrium Mixing", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "gel", "barrier_category": "skin", "barrier_name": "human skin", "api_name": "ibuprofen", "api_conc_raw": "10 mg/mL", "api_conc_value": 10.0, "api_conc_unit": "mg/mL", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 5.0, "unit": "mg", "time_value": 48.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "gelator 2·2Br", "concentration_raw": "10 mg/mL", "concentration_value": 10.0, "concentration_unit": "mg/mL", "concentration_basis": "w/w"}, {"name": "ibuprofen sodium salt", "concentration_raw": "5 mg/mL", "concentration_value": 5.0, "concentration_unit": "mg/mL", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 4", "snippet": "...the maximum amount of ibuprofen salt that can be released is around 55%, and after 40 h, half of this value is already reached."}, {"field": "barrier", "locator": "PAGE 6", "snippet": "the gels were studied for release in vitro using a Franz-cell system, with a receptor phase with pH 7.4..."}], "needs_supp": "no", "confidence": 0.95, "notes": "All values extracted correspond to stated concentrations and results from the text, with specific mention of the main endpoint."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1021_acsomega.7b01800__9d283ba697.pdf"}
{"doi": "10.3389/fphar.2024.1355283", "title": "Hyaluronic acid-ibuprofen conjugation: a novel ototherapeutic approach protecting inner ear cells from inflammation-mediated damage.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "hyaluronic acid-ibuprofen conjugate", "barrier_category": "both", "barrier_name": "tympanic membrane and round window membrane", "api_name": "ibuprofen", "api_conc_raw": "0.18 mg/mL", "api_conc_value": 0.18, "api_conc_unit": "mg/mL", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": null, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Hyaluronic acid", "concentration_raw": "unspecified", "concentration_value": null, "concentration_unit": "uncertain", "concentration_basis": "uncertain"}, {"name": "Ibuprofen", "concentration_raw": "0.18 mg/mL (estimated equivalent)", "concentration_value": 0.18, "concentration_unit": "mg/mL", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 8", "snippet": "The endpoint at the last reported time (Q_final@t_last) has no explicit numeric value stated."}, {"field": "api_concentration", "locator": "PAGE 8", "snippet": "the estimated equivalent concentration of unconjugated IBU (0.18 mg/mL) with LPS at 10 ng/mL."}], "needs_supp": "no", "confidence": 0.8, "notes": "Main endpoint (Q_final) not explicitly stated in numeric form, set to null."}], "extraction_notes": "The data primarily focus on the ibuprofen-hyaluronic acid conjugate and its permeation across barriers. No numeric values for cumulative amount permeated at the last time point were found; thus, that endpoint is recorded as null.", "pdf_path": "GenAI\\papers\\pdf\\10.3389_fphar.2024.1355283__d3e3b20e27.pdf"}
{"doi": "10.1021/acsami.4c00383", "title": "Coated Cotton Fabrics with Antibacterial and Anti-Inflammatory Silica Nanoparticles for Improving Wound Healing", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Coated Fabrics", "barrier_category": "both", "barrier_name": "Silica Nanoparticle Coated Cotton Fabrics", "api_name": "ibuprofen", "api_conc_raw": "0.23:0.23 mmol/g", "api_conc_value": null, "api_conc_unit": "mmol/g", "api_conc_basis": "other", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 48.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "0.23 mmol/g", "concentration_value": null, "concentration_unit": "mmol/g", "concentration_basis": "other"}, {"name": "levofloxacin", "concentration_raw": "0.075 mmol/g", "concentration_value": null, "concentration_unit": "mmol/g", "concentration_basis": "other"}], "evidence": [{"field": "api_concentration", "locator": "PAGE 1", "snippet": "A topical nonsteroidal anti-inflammatory agent, ibuprofen,..."}], "needs_supp": "yes", "confidence": 0.85, "notes": "Ibuprofen concentration details not fully provided; endpoint data inferred from figures, set to null."}], "extraction_notes": "Only one formulation regarding ibuprofen was clearly defined in the pages provided.", "pdf_path": "GenAI\\papers\\pdf\\10.1021_acsami.4c00383__86c11b19c2.pdf"}
{"doi": "10.1039/d2ra05804a", "title": "New amino acid propyl ester ibuprofenates from synthesis to use in drug delivery systems.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "transdermal patch", "barrier_category": "skin", "barrier_name": "pig skin", "api_name": "ibuprofen", "api_conc_raw": "4.775 ± 0.046 g IBU per dm3", "api_conc_value": 4.775, "api_conc_unit": "g/dm³", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 454.86, "unit": "mg/cm²", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 28.01, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "L-amino acid propyl ester ibuprofenate (PheOiPr)", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}, {"name": "other excipients", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}], "evidence": [{"field": "Q_final", "locator": "PAGE 5", "snippet": "the cumulative mass of penetrated compound was about ten times higher for the obtained derivatives than for ibuprofen. [PheOPr][IBU] was characterized by the most statistically significantly increased cumulative mass, and the cumulative amount of substance permeated during the 24 h study was 454.86 mg cm−2."}, {"field": "Flux", "locator": "PAGE 5", "snippet": "The steady-state flux of the [AAOPr][IBU] from ethanol solution was from 21.33 mg IBU per cm2 for [HisOPr][IBU], to 28.01 for [PheOPr][IBU]...higher flows of active substances were obtained."}], "needs_supp": "no", "confidence": 0.9, "notes": "Only one formulation was explicitly detailed with associated values and conditions."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1039_d2ra05804a__cf2f535409.pdf"}
{"doi": "10.1016/j.ijpharm.2016.03.043", "title": "A comparative study of the in vitro permeation of ibuprofen in mammalian skin, the PAMPA model and silicone membrane.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "IBUGEL™, IBULEVE™ Speed Relief", "barrier_category": "skin", "barrier_name": "Human skin", "api_name": "ibuprofen", "api_conc_raw": "5% w/w", "api_conc_value": null, "api_conc_unit": "", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 40.0, "unit": "µg/cm²", "time_value": 48.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "5% w/w", "concentration_value": 5.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Propylene Glycol (PG)", "concentration_raw": "unknown", "concentration_value": null, "concentration_unit": "unknown", "concentration_basis": "uncertain"}, {"name": "Polyethylene Glycol (PEG) 300", "concentration_raw": "unknown", "concentration_value": null, "concentration_unit": "unknown", "concentration_basis": "uncertain"}], "evidence": [{"field": "api_concentration", "locator": "PAGE 4", "snippet": "The commercial formulations selected for evaluation were IBUGEL™ (Ibuprofen 5% w/w)... "}, {"field": "Q_final", "locator": "PAGE 7", "snippet": "...maximum amounts of permeation were ~40 µg/cm2 in human skin after 48 h."}, {"field": "ingredients", "locator": "PAGE 7", "snippet": "...excipient, penetration enhancer: PG."}], "needs_supp": "no", "confidence": 0.95, "notes": "Ibuprofen concentration from formulations is provided as a raw value only."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1016_j.ijpharm.2016.03.043__7008480bdc.pdf"}
{"doi": "10.1016/j.ijpx.2023.100205", "title": "Enhanced stability and skin permeation of ibuprofen-loaded solid lipid nanoparticles based binary solid lipid matrix: Effect of surfactant and lipid compositions.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "SLNs", "barrier_category": "skin", "barrier_name": "human epidermis", "api_name": "ibuprofen", "api_conc_raw": "1% w/w", "api_conc_value": 1.0, "api_conc_unit": "% w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "CP", "concentration_raw": "9% w/w", "concentration_value": 9.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "S378", "concentration_raw": "0% w/w", "concentration_value": 0.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "TG450", "concentration_raw": "1.2% w/w", "concentration_value": 1.2, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "P188", "concentration_raw": "0% w/w", "concentration_value": 0.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "H2O", "concentration_raw": "q.s. to 100%", "concentration_value": null, "concentration_unit": "", "concentration_basis": "other"}], "evidence": [{"field": "Q_final", "locator": "PAGE 8", "snippet": "the cumulative amounts of ibuprofen released at 24 h, IBSLN1-TG450 showed the highest ibuprofen release (p < 0.05)"}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint value (Q_final) could not be quantified as exact values for cumulative amount were not reported."}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "SLNs", "barrier_category": "skin", "barrier_name": "human epidermis", "api_name": "ibuprofen", "api_conc_raw": "1% w/w", "api_conc_value": 1.0, "api_conc_unit": "% w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "CP", "concentration_raw": "4.5% w/w", "concentration_value": 4.5, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "S378", "concentration_raw": "4.5% w/w", "concentration_value": 4.5, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "TG450", "concentration_raw": "1.2% w/w", "concentration_value": 1.2, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "P188", "concentration_raw": "0% w/w", "concentration_value": 0.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "H2O", "concentration_raw": "q.s. to 100%", "concentration_value": null, "concentration_unit": "", "concentration_basis": "other"}], "evidence": [{"field": "Q_final", "locator": "PAGE 8", "snippet": "the cumulative amounts of ibuprofen released at 24 h, IBSLN1-TG450 showed the highest ibuprofen release (p < 0.05)"}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint value (Q_final) could not be quantified as exact values for cumulative amount were not reported."}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "SLNs", "barrier_category": "skin", "barrier_name": "human epidermis", "api_name": "ibuprofen", "api_conc_raw": "1% w/w", "api_conc_value": 1.0, "api_conc_unit": "% w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "CP", "concentration_raw": "0% w/w", "concentration_value": 0.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "S378", "concentration_raw": "9% w/w", "concentration_value": 9.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "TG450", "concentration_raw": "1% w/w", "concentration_value": 1.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "P188", "concentration_raw": "0% w/w", "concentration_value": 0.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "H2O", "concentration_raw": "q.s. to 100%", "concentration_value": null, "concentration_unit": "", "concentration_basis": "other"}], "evidence": [{"field": "Q_final", "locator": "PAGE 8", "snippet": "the cumulative amounts of ibuprofen released at 24 h, IBSLN1-TG450 showed the highest ibuprofen release (p < 0.05)"}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint value (Q_final) could not be quantified as exact values for cumulative amount were not reported."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1016_j.ijpx.2023.100205__36b2f722d0.pdf"}
{"doi": "10.1002/etc.4302", "title": "Effects of skin region and relative lipophilicity on percutaneous absorption in the toad Rhinella marina.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "solution", "barrier_category": "skin", "barrier_name": "ventral and dorsal skin", "api_name": "ibuprofen", "api_conc_raw": "2.75 g/L", "api_conc_value": 2.75, "api_conc_unit": "g/L", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "g", "time_value": 1440.0, "time_unit": "min"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "2.75 g/L", "concentration_value": 2.75, "concentration_unit": "g/L", "concentration_basis": "w/w"}, {"name": "HPβCD", "concentration_raw": "2.75 g/L", "concentration_value": 2.75, "concentration_unit": "g/L", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 8", "snippet": "...cumulative absorption versus time plots showed that absorption for the chemicals decreased in the order caffeine > benzoic acid > ibuprofen through all skin regions."}, {"field": "api_concentration", "locator": "PAGE 7", "snippet": "...the donor chamber was filled with a saturated solution of one of the model chemicals (caffeine, benzoic acid, or ibuprofen) in ARS ± HPβCD (“infinite dose” conditions). "}, {"field": "api_concentration_basis", "locator": "PAGE 7", "snippet": "...spiked with 2.75 g/L 2-hydroxypropyl-beta-cyclodextrin (HPβCD; Aldrich Chemistry) to assist solubilization in experiments using ibuprofen."}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint value for Q_final is not reported numerically; it could be found in supplemental material."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1002_etc.4302__89ec992d2c.pdf"}
{"doi": "10.1007/s11095-012-0939-6", "title": "Investigation of follicular and non-follicular pathways for polyarginine and oleic acid-modified nanoparticles.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "nanoparticle formulation", "barrier_category": "skin", "barrier_name": "pig ear skin", "api_name": "ibuprofen", "api_conc_raw": "1 mg/ml (Ibu solution)", "api_conc_value": null, "api_conc_unit": "mg/ml", "api_conc_basis": "other", "endpoint_main": {"endpoint_type": "Q_final", "value": 12.24, "unit": "μg/cm²", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "μg/cm²/h", "time_value": null, "time_unit": "null"}, {"endpoint_type": "Jss", "value": null, "unit": "μg/cm²/h", "time_value": null, "time_unit": "null"}], "ingredients": [{"name": "Nanoparticle formulation with ibuprofen", "concentration_raw": "Contains ibuprofen at a concentration of 1 mg/ml", "concentration_value": 1.0, "concentration_unit": "mg/ml", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 8", "snippet": "The amount of Ibu permeated into the receiver compartment... was 12.24 ± 0.81 μg/cm2 when HF were closed."}, {"field": "api_concentration", "locator": "PAGE 9", "snippet": "100 μl of surface modified and un-modified nanoparticle formulations including Ibu-NLC..."}], "needs_supp": "no", "confidence": 0.9, "notes": "Ibuprofen concentration value was based on the solution preparation method, considered as 1 mg/ml for calculation."}], "extraction_notes": "Single formulation of ibuprofen was studied; endpoints were derived from explicit numeric data in the text.", "pdf_path": "GenAI\\papers\\pdf\\10.1007_s11095-012-0939-6__6f8de36d1e.pdf"}
{"doi": "10.1007/s11095-020-02887-9", "title": "Two-Photon Polymerisation 3D Printing of Microneedle Array Templates with Versatile Designs: Application in the Development of Polymeric Drug Delivery Systems", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "microneedle array", "barrier_category": "skin", "barrier_name": "neonatal porcine skin", "api_name": "ibuprofen", "api_conc_raw": "40% w/w IBU Na in wafer reservoir with gelatin and mannitol", "api_conc_value": null, "api_conc_unit": "w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "gelatin", "concentration_raw": "10% w/w", "concentration_value": 10.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "mannitol", "concentration_raw": "3% w/w", "concentration_value": 3.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "ibuprofen sodium", "concentration_raw": "40% w/w", "concentration_value": 40.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 6", "snippet": "the HFMN arrays were then inserted into the skin by applying manual pressure for 30 s."}, {"field": "flux", "locator": "PAGE 4", "snippet": "Modified Franz diffusion cells were used in the permeation assay."}, {"field": "Jss", "locator": "PAGE 4", "snippet": "For the in vitro permeation of IBU Na using HFMN arrays, lyophilised wafer-like reservoirs."}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint values are not explicitly stated in the provided pages; hence, set to null. Explicit concentrations for ingredients based on formulation data."}], "extraction_notes": "Results extracted focus on the IVPT study using ibuprofen, specifically from microneedle array formulations. Values are not all explicitly available, especially regarding endpoints.", "pdf_path": "GenAI\\papers\\pdf\\10.1007_s11095-020-02887-9__71e83a4015.pdf"}
{"doi": "10.1016/j.heliyon.2019.e02127", "title": "Permeability of frog skin to chemicals: effect of penetration enhancers", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "solution", "barrier_category": "skin", "barrier_name": "Rh. marina skin", "api_name": "ibuprofen", "api_conc_raw": "saturated; 0.243 g/L at 1% v/v ethanol", "api_conc_value": 0.243, "api_conc_unit": "g/L", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "g", "time_value": 6.0, "time_unit": "hr"}, "endpoint_optional": [], "ingredients": [{"name": "Ethanol", "concentration_raw": "10% v/v", "concentration_value": 10.0, "concentration_unit": "%", "concentration_basis": "v/v"}, {"name": "HPβCD", "concentration_raw": "2.75 mg/ml", "concentration_value": null, "concentration_unit": "mg/ml", "concentration_basis": "other"}], "evidence": [{"field": "Q_final", "locator": "PAGE 5", "snippet": "...Cumulative absorption versus time curves for ibuprofen through dorsal skin showed a much higher absorption... from 10% and 30% v/v ethanol compared to 1% v/v ethanol, PG and ARS..."}], "needs_supp": "no", "confidence": 0.0, "notes": "Main endpoint Q_final is based on figures; no explicit numeric value available."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1016_j.heliyon.2019.e02127__2845bde3ad.pdf"}
{"doi": "10.3390/polym15040791", "title": "Chitin-Glucan Complex Hydrogels: Physical-Chemical Characterization, Stability, In Vitro Drug Permeation, and Biological Assessment in Primary Cells.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Hydrogel", "barrier_category": "skin", "barrier_name": "Strat-M", "api_name": "ibuprofen", "api_conc_raw": "11.25 mg/cm3", "api_conc_value": 11.25, "api_conc_unit": "mg/cm3", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 35.37, "unit": "µg/cm2", "time_value": null, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 4.26, "unit": "µg/cm2/h", "time_value": null, "time_unit": "h"}, {"endpoint_type": "Jss", "value": null, "unit": "µg/cm2/h", "time_value": null, "time_unit": "h"}], "ingredients": [{"name": "Chitin-Glucan Complex", "concentration_raw": "Na51*4", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}], "evidence": [{"field": "Q_final", "locator": "PAGE 17", "snippet": "the maximum cumulative amount of 35.37 ± 2.77 µg/cm2 was achieved for ibuprofen."}, {"field": "flux", "locator": "PAGE 15", "snippet": "salicylic acid and ibuprofen, which were permeated with a flux of 19.53 and 4.26 µg/cm2/h, respectively."}], "needs_supp": "no", "confidence": 0.9, "notes": "Ibuprofen concentration value based on loading solution, not experimental outcome."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.3390_polym15040791__a37a825452.pdf"}
{"doi": "10.3390/pharmaceutics12020105", "title": "Development of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D Printing", "records": [{"study_type": "IVPT", "cell_type": "diffusion_cell_unspecified", "dosage_form": "implant", "barrier_category": "skin", "barrier_name": "not specified", "api_name": "ibuprofen", "api_conc_raw": "68.1 ± 3.0 mg", "api_conc_value": 68.1, "api_conc_unit": "mg", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": null, "time_unit": "hours"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen sodium", "concentration_raw": "68.1 ± 3.0 mg", "concentration_value": 68.1, "concentration_unit": "mg", "concentration_basis": "w/w"}, {"name": "PVA", "concentration_raw": "n/a", "concentration_value": null, "concentration_unit": "n/a", "concentration_basis": "other"}, {"name": "PLA", "concentration_raw": "n/a", "concentration_value": null, "concentration_unit": "n/a", "concentration_basis": "other"}], "evidence": [{"field": "api_concentration", "locator": "PAGE 4", "snippet": "Implants were loaded with MB (68.6 ± 5.1 mg), IS (68.1 ± 3.0 mg) or IA (72.3 ± 3.2 mg)."}, {"field": "endpoint", "locator": "PAGE 11", "snippet": "Implants with 1.0 × 1.0 mm 'windows' were capable of providing drug release over 25 days."}, {"field": "release profile", "locator": "PAGE 11", "snippet": "Release profiles of IS from Implants B and E are shown in Figure 7A."}], "needs_supp": "yes", "confidence": 0.8, "notes": "Endpoint main value is not provided explicitly, hence set to null. Additional supplementary information may be needed."}], "extraction_notes": "Data extracted from the provided PDF pages. Some values were not explicitly presented and are therefore set to null.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_pharmaceutics12020105__15075ef150.pdf"}
{"doi": "10.3390/pharmaceutics2020209", "title": "A Comparative Study of Transmembrane Diffusion and Permeation of Ibuprofen across Synthetic Membranes Using Franz Diffusion Cells.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "saturated solution", "barrier_category": "synthetic_membrane", "barrier_name": "Cellulose nitrate", "api_name": "ibuprofen", "api_conc_raw": "2.116 % w/v", "api_conc_value": null, "api_conc_unit": "% w/v", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 97.89, "unit": "mg/cm2", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 17.65, "unit": "mg/cm2/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "", "time_value": null, "time_unit": ""}], "ingredients": [], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 6", "snippet": "The average ibuprofen solubility at 25, 33, 37 and 60 ºC was 1.962 ± 0.002, 1.963 ± 0.002, 1.953 ± 0.001 and 2.116 ± 0.08 % w/v."}, {"field": "Q_final", "locator": "PAGE 8", "snippet": "Total diffusion after 6 h (mg/cm2) 97.89 ± 5.79."}, {"field": "flux", "locator": "PAGE 8", "snippet": "Cellulose nitrate 17.65 ± 2.06 mg/cm2/h."}], "needs_supp": "no", "confidence": 0.95, "notes": "Endpoint values extracted. No supplemental information needed."}], "extraction_notes": "Extracted the relevant information according to the specified criteria, ensuring that the details about the formulation and the endpoints matched the requirements.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_pharmaceutics2020209__1a2e9fadde.pdf"}
{"doi": "10.3390/antibiotics10070805", "title": "In Vitro Microbiological and Drug Release of Silver/Ibuprofen Loaded Wound Dressing Designed for the Treatment of Chronically Infected Painful Wounds.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "ibuprofen lysinate (IBU-L)", "barrier_category": "skin", "barrier_name": "non-woven PET textiles", "api_name": "ibuprofen", "api_conc_raw": "500 µg/cm²", "api_conc_value": 500.0, "api_conc_unit": "µg/cm²", "api_conc_basis": "uncertain", "endpoint_main": {"endpoint_type": "Q_final", "value": 187.0, "unit": "µg/cm²", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen lysinate", "concentration_raw": "500 µg/cm²", "concentration_value": 500.0, "concentration_unit": "µg/cm²", "concentration_basis": "uncertain"}, {"name": "Chitosan", "concentration_raw": "uncertain", "concentration_value": null, "concentration_unit": "uncertain", "concentration_basis": "uncertain"}, {"name": "Poly(cyclodextrin citrate)", "concentration_raw": "uncertain", "concentration_value": null, "concentration_unit": "uncertain", "concentration_basis": "uncertain"}], "evidence": [{"field": "Q_final", "locator": "PAGE 14", "snippet": "the total IBU-L loaded (187 ± 5 µg/cm²) was also released after 6 h."}, {"field": "api_conc_raw", "locator": "PAGE 13", "snippet": "the amount of IBU-L adsorbed onto PET-CD-Ag-PEM was 187 ± 5 µg/cm²."}], "needs_supp": "no", "confidence": 0.95, "notes": "Ibuprofen concentration was stated in context of total release; concentrations of other ingredients were not specified."}], "extraction_notes": "Only one formulation clearly defined, hence only one record extracted.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_antibiotics10070805__b6bca2ab5d.pdf"}
{"doi": "10.3390/ma10010074", "title": "Supercritical CO₂-Assisted Spray Drying of Strawberry-Like Gold-Coated Magnetite Nanocomposites in Chitosan Powders for Inhalation", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "microparticles", "barrier_category": "skin", "barrier_name": "lung epithelium", "api_name": "ibuprofen", "api_conc_raw": "71.7% entrapment efficiency", "api_conc_value": null, "api_conc_unit": "%", "api_conc_basis": "uncertain", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 10.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 23.1, "unit": "h−1", "time_value": 10.0, "time_unit": "h"}, {"endpoint_type": "Jss", "value": 19.2, "unit": "%", "time_value": 10.0, "time_unit": "h"}], "ingredients": [{"name": "Chitosan", "concentration_raw": "Mix with nanoparticles", "concentration_value": null, "concentration_unit": "null", "concentration_basis": "uncertain"}, {"name": "Gold-Coated Magnetite Nanoparticles", "concentration_raw": "Embedded in microparticles", "concentration_value": null, "concentration_unit": "null", "concentration_basis": "uncertain"}], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 8", "snippet": "Entrapment efﬁciency was calculated to estimate the number of nanoparticles and IBP that remained in the CHT matrix after particle engineering. For microparticles with IBP entrapped... the entrapment efﬁciency was 71.7% for IBP."}, {"field": "Q_final", "locator": "PAGE 13", "snippet": "80% release after 10 h at pH 6.8 condition."}, {"field": "flux", "locator": "PAGE 8", "snippet": "k (h−1) value for pH 7.4 is 23.1."}, {"field": "Jss", "locator": "PAGE 8", "snippet": "k (h−1) value for pH 6.8 is 19.2."}], "needs_supp": "no", "confidence": 0.9, "notes": "The specific cumulative amount permeated/released (Q_final) is not numerically stated; set to null."}], "extraction_notes": "Data extracted corresponds to the available information regarding ibuprofen in formulations. Specific numeric values for some endpoints are not provided in the text.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_ma10010074__5bcebc0cec.pdf"}
{"doi": "10.1186/s12951-020-00718-y", "title": "Synthesis and application of magnetic@layered double hydroxide as an anti-inflammatory drugs nanocarrier", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "nanostructure", "barrier_category": "both", "barrier_name": "Fe3O4@LDH", "api_name": "ibuprofen", "api_conc_raw": "3 g in 100 mL", "api_conc_value": null, "api_conc_unit": "mg/mL", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "%", "time_value": 72.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "ng/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "ng/cm²/s", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "3 g in 100 mL PBS (pH 7.4)", "concentration_value": null, "concentration_unit": "mg/mL", "concentration_basis": "w/w"}], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 10", "snippet": "Ibuprofen 96 7.4"}, {"field": "Q_final", "locator": "PAGE 9", "snippet": "the maximum amount of 90% for Ibuprofen and 78% for Diclofenac in the first 6 h."}, {"field": "release_profile", "locator": "PAGE 8", "snippet": "Both drug releases gently increased within 15 min to 6 h interval."}], "needs_supp": "no", "confidence": 0.85, "notes": "No numeric value for Q_final reported in the main text; expected to be noted in supplementary materials."}], "extraction_notes": "Only one distinct formulation with ibuprofen identified in provided text.", "pdf_path": "GenAI\\papers\\pdf\\10.1186_s12951-020-00718-y__c400793e91.pdf"}
{"doi": "10.1208/s12249-010-9522-9", "title": "Validation of a static Franz diffusion cell system for in vitro permeation studies.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Phorpain gel (5% ibuprofen)", "barrier_category": "synthetic_membrane", "barrier_name": "Visking cellulose membrane", "api_name": "ibuprofen", "api_conc_raw": "5%", "api_conc_value": 50.0, "api_conc_unit": "mg/g", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 36.4, "unit": "μg/cm²", "time_value": 7.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 36.4, "unit": "μg/cm²/h", "time_value": null, "time_unit": "null"}], "ingredients": [{"name": "ibuprofen", "concentration_raw": "5%", "concentration_value": 50.0, "concentration_unit": "mg/g", "concentration_basis": "w/w"}, {"name": "hydroxyethyl cellulose", "concentration_raw": "unspecified", "concentration_value": null, "concentration_unit": "null", "concentration_basis": "uncertain"}, {"name": "sodium hydroxide", "concentration_raw": "unspecified", "concentration_value": null, "concentration_unit": "null", "concentration_basis": "uncertain"}, {"name": "benzyl alcohol", "concentration_raw": "unspecified", "concentration_value": null, "concentration_unit": "null", "concentration_basis": "uncertain"}, {"name": "isopropyl alcohol", "concentration_raw": "unspecified", "concentration_value": null, "concentration_unit": "null", "concentration_basis": "uncertain"}, {"name": "purified water", "concentration_raw": "unspecified", "concentration_value": null, "concentration_unit": "null", "concentration_basis": "uncertain"}], "evidence": [{"field": "Q_final", "locator": "PAGE 8", "snippet": "the calculated steady-state flux value was 36.4±0.6 μg cm−2h−1"}, {"field": "api_concentration", "locator": "PAGE 6", "snippet": "Phorpain gel containing 5% ibuprofen"}], "needs_supp": "no", "confidence": 1.0, "notes": "Concentration of ibuprofen in Phorpain gel was stated as 5% w/w."}], "extraction_notes": "Extracted data primarily from studies with ibuprofen formulations mentioned explicitly.", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-010-9522-9__9004f70379.pdf"}
{"doi": "10.1155/2015/892671", "title": "Formulation of Novel Layered Sodium Carboxymethylcellulose Film Wound Dressings with Ibuprofen for Alleviating Wound Pain.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "film", "barrier_category": "skin", "barrier_name": "sodium carboxymethylcellulose film", "api_name": "ibuprofen", "api_conc_raw": "0.5 mg/cm2", "api_conc_value": 0.5, "api_conc_unit": "mg/cm2", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 8.0, "time_unit": "hours"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg/cm2/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "mg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "sodium carboxymethylcellulose", "concentration_raw": "0.5 mg/cm2", "concentration_value": 0.5, "concentration_unit": "mg/cm2", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 6", "snippet": "...0.5-Ibu-1 demonstrated higher drug content uniformity and superior in vitro drug release characteristics..."}], "needs_supp": "yes", "confidence": 0.8, "notes": "Main endpoint is from a figure without clear numeric value stated."}, {"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "film", "barrier_category": "skin", "barrier_name": "sodium carboxymethylcellulose film", "api_name": "ibuprofen", "api_conc_raw": "1.0 mg/cm2", "api_conc_value": 1.0, "api_conc_unit": "mg/cm2", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 8.0, "time_unit": "hours"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg/cm2/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "mg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "sodium carboxymethylcellulose", "concentration_raw": "1.0 mg/cm2", "concentration_value": 1.0, "concentration_unit": "mg/cm2", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 6", "snippet": "...0.5-Ibu-1 demonstrated higher drug content uniformity and superior in vitro drug release characteristics..."}], "needs_supp": "yes", "confidence": 0.8, "notes": "Main endpoint is from a figure without clear numeric value stated."}], "extraction_notes": "Extracted multiple formulations due to distinct conditions, but note that many endpoint values are inferred from narrative and may require supplemental material.", "pdf_path": "GenAI\\papers\\pdf\\10.1155_2015_892671__9b42388c10.pdf"}
{"doi": "10.1208/s12249-019-1481-1", "title": "Effects of Temperature and Humidity on the Skin Permeation of Hydrophilic and Hydrophobic Drugs.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "saturated solution", "barrier_category": "skin", "barrier_name": "porcine ear skin", "api_name": "ibuprofen", "api_conc_raw": "saturated solution", "api_conc_value": null, "api_conc_unit": "-", "api_conc_basis": "uncertain", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "μg/cm²", "time_value": 8.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 3.12, "unit": "μg/cm²/h", "time_value": null, "time_unit": "null"}, {"endpoint_type": "Jss", "value": 41.4, "unit": "μg/cm²", "time_value": null, "time_unit": "null"}], "ingredients": [{"name": "glycerin", "concentration_raw": "24 wt%", "concentration_value": 24.0, "concentration_unit": "wt%", "concentration_basis": "w/w"}, {"name": "1,3-propanediol", "concentration_raw": "6 wt%", "concentration_value": 6.0, "concentration_unit": "wt%", "concentration_basis": "w/w"}, {"name": "1,3-butanediol", "concentration_raw": "5 wt%", "concentration_value": 5.0, "concentration_unit": "wt%", "concentration_basis": "w/w"}, {"name": "dipropylene glycol", "concentration_raw": "4 wt%", "concentration_value": 4.0, "concentration_unit": "wt%", "concentration_basis": "w/w"}, {"name": "polyoxyethylene (60) hydrogenated castor oil", "concentration_raw": "3 wt%", "concentration_value": 3.0, "concentration_unit": "wt%", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 6", "snippet": "The Q values of IP at T48RH95, T50RH55, and T52RH30 (40°C, skin surface temperature) were higher compared with those at T27RH55."}, {"field": "flux", "locator": "PAGE 6", "snippet": "Small but significant increases in P for IP at T50RH55 and T52RH30."}, {"field": "Jss", "locator": "PAGE 6", "snippet": "P for IP at T48RH95 was 41.4 ± 7.28."}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint main Q_final value is marked as null as it was not explicitly stated numerically."}], "extraction_notes": "Confidence in the extracted data is high based on the explicit details provided in the text.", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-019-1481-1__47e0b4fbb9.pdf"}
{"doi": "10.1208/s12249-019-1584-8", "title": "Transcutol® P/Cremophor® EL/Ethyl Oleate-Formulated Microemulsion Loaded into Hyaluronic Acid-Based Hydrogel for Improved Transdermal Delivery and Biosafety of Ibuprofen", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "ME/Gel", "barrier_category": "skin", "barrier_name": "rat skin", "api_name": "ibuprofen", "api_conc_raw": "5%", "api_conc_value": 5.0, "api_conc_unit": "%", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 12.5, "unit": "mg", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 0.52, "unit": "mg/cm²/h", "time_value": null, "time_unit": "null"}, {"endpoint_type": "Jss", "value": null, "unit": "null", "time_value": null, "time_unit": "null"}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "5%", "concentration_value": 5.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Ethyl oleate", "concentration_raw": "4%", "concentration_value": 4.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Cremophor® EL", "concentration_raw": "18%", "concentration_value": 18.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Transcutol® P", "concentration_raw": "18%", "concentration_value": 18.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Azone", "concentration_raw": "1%", "concentration_value": 1.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Hyaluronic Acid", "concentration_raw": "1%", "concentration_value": 1.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Water", "concentration_raw": "53%", "concentration_value": 53.0, "concentration_unit": "%", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 8", "snippet": "the cumulative permeation of ibuprofen in the ME/Gel group was the largest (Fig. 3a, p < 0.01),"}, {"field": "flux", "locator": "PAGE 8", "snippet": "transdermal flux was also 1.42-fold greater than those of the above preparation groups (Fig. 3b, p < 0.01)."}], "needs_supp": "no", "confidence": 0.95, "notes": "The values for Jss are not explicitly stated, marked as null."}], "extraction_notes": "Only one distinct formulation was provided with explicit details.", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-019-1584-8__85f231cdcc.pdf"}
{"doi": "10.1007/s13346-022-01182-x", "title": "Soluplus® polymeric nanomicelles improve solubility of BCS-class II drugs.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "micelles", "barrier_category": "both", "barrier_name": "Soluplus® nanomicelles", "api_name": "ibuprofen", "api_conc_raw": "0.5% (w/v)", "api_conc_value": 5.0, "api_conc_unit": "mg/mL", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 74.0, "unit": "%", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "null", "time_value": null, "time_unit": "null"}, {"endpoint_type": "Jss", "value": null, "unit": "null", "time_value": null, "time_unit": "null"}], "ingredients": [{"name": "Soluplus®", "concentration_raw": "1.5 mM", "concentration_value": 1.5, "concentration_unit": "mM", "concentration_basis": "uncertain"}, {"name": "Ibuprofen", "concentration_raw": "0.5% (w/v)", "concentration_value": 5.0, "concentration_unit": "mg/mL", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 8", "snippet": "...reaching a 74% value after 24 h."}, {"field": "api_concentration", "locator": "PAGE 3", "snippet": "IBU: 0.5% (w/v) (batch SNM-IBU1)"}], "needs_supp": "no", "confidence": 0.95, "notes": "Endpoint values and concentrations taken directly from text; uncertainty in concentration basis justifies 'uncertain' label."}], "extraction_notes": "Extracted data reflects distinct formulation conditions for ibuprofen in the study.", "pdf_path": "GenAI\\papers\\pdf\\10.1007_s13346-022-01182-x__b21c07f7ac.pdf"}
{"doi": "10.1039/d0ra06567f", "title": "The effect of alcohols as vehicles on the percutaneous absorption and skin retention of ibuprofen modified with l-valine alkyl esters.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Solution", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "70% i-propanol solution", "api_conc_value": null, "api_conc_unit": "v/v", "api_conc_basis": "uncertain", "endpoint_main": {"endpoint_type": "Q_final", "value": 411.76, "unit": "mg IBU cm^-2", "time_value": 24.0, "time_unit": "hours"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg cm^-2 h^-1", "time_value": null, "time_unit": "null"}, {"endpoint_type": "Jss", "value": null, "unit": "mg cm^-2 h^-1", "time_value": null, "time_unit": "null"}], "ingredients": [{"name": "L-valine propyl ester", "concentration_raw": "41.60%", "concentration_value": 41.6, "concentration_unit": "%", "concentration_basis": "v/v"}, {"name": "i-propanol", "concentration_raw": "70% (v/v)", "concentration_value": 70.0, "concentration_unit": "%", "concentration_basis": "v/v"}], "evidence": [{"field": "Q_final", "locator": "PAGE 6", "snippet": "the highest IBU cumulative masses, 411.76 mg IBU cm^-2 ... from i-propanol solution"}, {"field": "formulation", "locator": "PAGE 6", "snippet": "donor phase was a 1% (m/v) solution of the tested compound, which was dissolved in an aqueous solution of"}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint main value derived from cumulative mass; values for api concentration and optional endpoints are not explicitly stated."}], "extraction_notes": "Extracted data reflects the specified requirements, focusing on a single formulation with ibuprofen due to the clarity of provided details.", "pdf_path": "GenAI\\papers\\pdf\\10.1039_d0ra06567f__15dc420ec6.pdf"}
{"doi": "10.1021/acs.langmuir.2c02497", "title": "pH-Responsive Metal-Organic Framework Thin Film for Drug Delivery", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "solution", "barrier_category": "skin", "barrier_name": "n/a", "api_name": "ibuprofen", "api_conc_raw": "0.5 mg/mL", "api_conc_value": 0.5, "api_conc_unit": "mg/mL", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "μg/cm²", "time_value": 55.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "μg/cm²/h", "time_value": null, "time_unit": "n/a"}, {"endpoint_type": "Jss", "value": null, "unit": "n/a", "time_value": null, "time_unit": "n/a"}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "0.5 mg/mL", "concentration_value": 0.5, "concentration_unit": "mg/mL", "concentration_basis": "w/v"}, {"name": "MIL-88B(Fe)", "concentration_raw": "6.0 μg/cm²", "concentration_value": 6.0, "concentration_unit": "μg/cm²", "concentration_basis": "w/w"}], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 3", "snippet": "the sample was incubated in a freshly prepared 0.5 mg/mL of ibuprofen in hexane solution"}, {"field": "Q_final", "locator": "PAGE 6", "snippet": "the amount of drug released in acidic environments had been significantly higher compared to that in a neutral system within 55 h of testing time."}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint Q_final was referenced but not explicitly quantified in numeric form; thus, set to null for specificity."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1021_acs.langmuir.2c02497__57371a22bd.pdf"}
{"doi": "10.1021/acs.molpharmaceut.1c00988", "title": "Elucidating the Impact of Surfactants on the Performance of Dissolving Microneedle Array Patches", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "dissolving microneedle array patches", "barrier_category": "skin", "barrier_name": "neonatal porcine skin", "api_name": "ibuprofen", "api_conc_raw": "30% drug, 20% w/w aqueous polymer blend (PVA and PVP), 50% surfactant solution", "api_conc_value": null, "api_conc_unit": "% w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 75.0, "unit": "%", "time_value": 1.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": ",", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": ",", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "ibuprofen sodium", "concentration_raw": "30%", "concentration_value": 30.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "PVA", "concentration_raw": "20%", "concentration_value": 20.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "PVP", "concentration_raw": "20%", "concentration_value": 20.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "surfactant (Tween 80, Pluronic F88, Lutrol F108)", "concentration_raw": "50%", "concentration_value": 50.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 12", "snippet": "the incorporation of surfactant enhanced the delivery eﬃciency of both model drugs, ibuprofen sodium and itraconazole."}, {"field": "Q_final", "locator": "PAGE 12", "snippet": "the control formulation only displayed a delivery eﬃciency of 60.61%. However, the addition of surfactant resulted in an increase in the drug delivery eﬃciency of up to ≈75% into and across the skin."}], "needs_supp": "no", "confidence": 0.9, "notes": "Ibuprofen concentration specified as a percentage in a formulation; endpoint values derived from explicit text."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1021_acs.molpharmaceut.1c00988__320ca28dae.pdf"}
{"doi": "10.1038/s41598-022-05912-6", "title": "Hard polymeric porous microneedles on stretchable substrate for transdermal drug delivery", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "microneedles", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "1 mg", "api_conc_value": 1.0, "api_conc_unit": "mg", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 1.0, "unit": "mg", "time_value": 2.0, "time_unit": "hours"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "mg/cm²/s", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen sodium salt", "concentration_raw": "1 mg", "concentration_value": 1.0, "concentration_unit": "mg", "concentration_basis": "w/w"}, {"name": "biocompatible/photo-curable resin", "concentration_raw": "1:1", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 8", "snippet": "Each patch (containing 100 microneedles) roughly releases 1 mg of drug in DPBS solution after 2 h by dissolution-diffusion mechanism."}, {"field": "Q_final", "locator": "PAGE 8", "snippet": "Each patch (containing 100 microneedles) roughly releases 1 mg of drug in DPBS solution after 2 h by dissolution-diffusion mechanism."}], "needs_supp": "no", "confidence": 0.95, "notes": "The concentration of ibuprofen is provided as total dose per patch, specific concentration per volume is not stated; hence, api_conc_value is marked as numeric."}], "extraction_notes": "Extraction performed based on explicit data regarding ibuprofen and its delivery system; no specific numerical endpoints were stated for optional parameters.", "pdf_path": "GenAI\\papers\\pdf\\10.1038_s41598-022-05912-6__a14138d102.pdf"}
{"doi": "10.1063/1.4946867", "title": "Attenuated total reflection-Fourier transform infrared spectroscopic imaging of pharmaceuticals in microfluidic devices.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "micro-formulation", "barrier_category": "both", "barrier_name": "neutral and acidic media", "api_name": "ibuprofen", "api_conc_raw": "200 mg/ml, 100 mg/ml, 50 mg/ml", "api_conc_value": null, "api_conc_unit": "mg/ml", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 20.0, "time_unit": "min"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "1:3 w/w", "concentration_value": null, "concentration_unit": "null", "concentration_basis": "w/w"}, {"name": "polyethylene glycol (PEG)", "concentration_raw": "1:3 w/w", "concentration_value": null, "concentration_unit": "null", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 7", "snippet": "complete release of ibuprofen in the pH 7 aqueous medium is observed after 20 min."}, {"field": "api_concentration", "locator": "PAGE 6", "snippet": "Three different concentrations of sodium ibuprofen dissolved in a neutral solution were studied in this investigation, 200 mg/ml, 100 mg/ml, and 50 mg/ml."}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint value is null due to lack of explicit numeric reporting in text; figure-based information used here has no numeric values stated."}], "extraction_notes": "Data extracted focuses on ibuprofen micro-formulations and their dissolution behavior in variable pH conditions. Documentation primarily discusses methodology rather than explicit numeric results.", "pdf_path": "GenAI\\papers\\pdf\\10.1063_1.4946867__507064c9a2.pdf"}
{"doi": "10.3390/polym16142006", "title": "Cellulose Acetate and Polycaprolactone Fibre Coatings on Medical-Grade Metal Substrates for Controlled Drug Release.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "membrane", "barrier_category": "skin", "barrier_name": "medical-grade stainless steel (SS-316 type)", "api_name": "ibuprofen", "api_conc_raw": "0.5 g/L", "api_conc_value": 0.5, "api_conc_unit": "g/L", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 0.498, "unit": "mg", "time_value": 190.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Cellulose Acetate", "concentration_raw": "12% w/v", "concentration_value": null, "concentration_unit": "", "concentration_basis": "w/w"}, {"name": "Polycaprolactone", "concentration_raw": "5% w/v", "concentration_value": null, "concentration_unit": "", "concentration_basis": "w/w"}, {"name": "Chitosan", "concentration_raw": "0.5% w/v", "concentration_value": null, "concentration_unit": "", "concentration_basis": "w/w"}, {"name": "Ibuprofen", "concentration_raw": "0.5 g/L", "concentration_value": 0.5, "concentration_unit": "g/L", "concentration_basis": "w/w"}], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 9", "snippet": "Ibu Released (mg) 0.498"}, {"field": "Q_final", "locator": "PAGE 9", "snippet": "Ibu Released (mg) 0.498"}], "needs_supp": "no", "confidence": 1.0, "notes": "All values for endpoints are explicitly stated in text; concentrations are provided as raw values."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.3390_polym16142006__02ac8ba9aa.pdf"}
{"doi": "10.14440/jbm.2020.319", "title": "An <i>ex vivo</i> skin model to probe modulation of local cutaneous arachidonic acid inflammation pathway", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "cream", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "20 mg", "api_conc_value": 20.0, "api_conc_unit": "mg", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/cm²", "time_value": null, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": "h"}, {"endpoint_type": "Jss", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": "h"}], "ingredients": [{"name": "ibuprofen", "concentration_raw": "20 mg", "concentration_value": 20.0, "concentration_unit": "mg", "concentration_basis": "w/w"}, {"name": "cream base", "concentration_raw": "unknown", "concentration_value": null, "concentration_unit": "null", "concentration_basis": "other"}], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 3", "snippet": "...including NSAID products such as Ibuleve (ibuprofen)..."}, {"field": "Q_final", "locator": "PAGE 5", "snippet": "...the amount of drug localized at different stratigraphic/histological layers within the skin."}, {"field": "flux", "locator": "PAGE 5", "snippet": "...to determine transdermal delivery parameters such as steady state flux and lag time."}], "needs_supp": "yes", "confidence": 0.7, "notes": "The main endpoint and optional endpoints (flux, Jss) values were not explicitly stated in numeric format; metrics set to null and noted since no figures provided specific numeric data."}], "extraction_notes": "No explicit numeric values for endpoints; reliance on supplementary information is indicated.", "pdf_path": "GenAI\\papers\\pdf\\10.14440_jbm.2020.319__1be6b1975c.pdf"}
{"doi": "10.1248/cpb.c21-00033", "title": "Use of Silicone Membrane Permeation to Assess Thermodynamic Activities of Ionic Liquids and Their Component Cation and Anion", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Ionic liquid (ibuprofen + lidocaine)", "barrier_category": "synthetic_membrane", "barrier_name": "silicone membrane", "api_name": "ibuprofen", "api_conc_raw": "0.8 (molar fraction of ibuprofen)", "api_conc_value": null, "api_conc_unit": "mol/L", "api_conc_basis": "other", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "µmol", "time_value": 8.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 1.18, "unit": "µmol/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "ibuprofen", "concentration_raw": "0.8 (molar fraction)", "concentration_value": 0.8, "concentration_unit": "mol/L", "concentration_basis": "other"}, {"name": "lidocaine", "concentration_raw": "0.2 (molar fraction)", "concentration_value": 0.2, "concentration_unit": "mol/L", "concentration_basis": "other"}], "evidence": [{"field": "Q_final", "locator": "PAGE 4", "snippet": "lidocaine or ibuprofen when their activity in water was 1.0 (lidocaine and ibuprofen permeation rates from the suspended aqueous solution were 7.92 ± 0.39 and 2.35 ± 0.20 µmol/cm2/h, respectively...)"}, {"field": "flux", "locator": "PAGE 4", "snippet": "theoretical membrane permeation rate of IL itself was fastest from the IL preparation #5"}], "needs_supp": "no", "confidence": 0.8, "notes": "Main endpoint Q_final is not explicitly provided as a numeric value. The flux value is explicitly reported."}], "extraction_notes": "Only one distinct formulation for ibuprofen was found in the provided text.", "pdf_path": "GenAI\\papers\\pdf\\10.1248_cpb.c21-00033__567266ad06.pdf"}
{"doi": "10.1038/sj.bjp.0702427", "title": "In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "solution", "barrier_category": "skin", "barrier_name": "rat skin", "api_name": "ibuprofen", "api_conc_raw": "5 mg/ml", "api_conc_value": 5.0, "api_conc_unit": "mg/ml", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "ng/ml", "time_value": null, "time_unit": ""}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "ng/(cm²·h)", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "ng/(cm²·h)", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "ibuprofen", "concentration_raw": "5 mg/ml", "concentration_value": 5.0, "concentration_unit": "mg/ml", "concentration_basis": "w/v"}], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 6", "snippet": "S(+) ibuprofen was included with capsaicin in the stimulation sample (i.e. 10 mM capsaicin+0.1, 1.0 or 10.0 mM ibuprofen in the second 10 min sample)."}, {"field": "Q_final", "locator": "PAGE 6", "snippet": "... the ability of the non-selective COX inhibitor S(+) ibuprofen to block this release was explored."}], "needs_supp": "no", "confidence": 0.85, "notes": "Numerical values for endpoints only presented in narrative or figures without specific numeric values."}], "extraction_notes": "Extracted data is based solely on explicitly stated information within the provided text. Some endpoints could not be determined in numeric form and are marked null accordingly.", "pdf_path": "GenAI\\papers\\pdf\\10.1038_sj.bjp.0702427__4215057e1b.pdf"}
{"doi": "10.1038/s41598-025-89540-w", "title": "Multi spectroscopic investigation of maisine-based microemulsions as convenient carriers for co-delivery of anticancer and anti-inflammatory drugs.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "microemulsion", "barrier_category": "skin", "barrier_name": "human skin", "api_name": "ibuprofen", "api_conc_raw": "1%", "api_conc_value": 1.0, "api_conc_unit": "% w/v", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 96.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 0.2, "unit": "mg/cm2/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": 0.1, "unit": "mg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Maisine CC", "concentration_raw": "2g", "concentration_value": 2.0, "concentration_unit": "g", "concentration_basis": "w/w"}, {"name": "Tween 20", "concentration_raw": "0.2g", "concentration_value": 0.2, "concentration_unit": "g", "concentration_basis": "w/w"}, {"name": "Ethanol", "concentration_raw": "0.1g", "concentration_value": 0.1, "concentration_unit": "g", "concentration_basis": "w/w"}], "evidence": [{"field": "q_final", "locator": "PAGE 4", "snippet": "The controlled release of the drugs from both types of lipid-based carriers was assessed by the dialysis bag method."}, {"field": "api_concentration", "locator": "PAGE 3", "snippet": "The optimized ME was loaded with the FU and IBU at various mass ratios (1:1, 1:3, 1:6)."}, {"field": "flux", "locator": "PAGE 6", "snippet": "The flux of permeation across the skin was calculated as 0.2 mg/cm2/h."}, {"field": "Jss", "locator": "PAGE 6", "snippet": "Jss for the formulations was measured and found to be 0.1 mg/cm2/h."}, {"field": "ingredients", "locator": "PAGE 6", "snippet": "The final composition of the nine drug(s)-loaded MEs includes Maisine CC and Tween 20."}], "needs_supp": "no", "confidence": 0.95, "notes": "Main endpoint value for Q_final is not explicitly reported in numeric format; therefore set to null. Other endpoints were clearly reported."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1038_s41598-025-89540-w__8b4b299fb0.pdf"}
{"doi": "10.1208/s12249-013-9953-1", "title": "Drug-loaded zein nanofibers prepared using a modified coaxial electrospinning process", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "nanofibers", "barrier_category": "skin", "barrier_name": "human skin", "api_name": "ibuprofen", "api_conc_raw": "3.0 g/30.0 g zein in 100 mL", "api_conc_value": 0.1, "api_conc_unit": "g/mL", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 97.1, "unit": "%", "time_value": 6.0, "time_unit": "hours"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "unknown", "time_value": null, "time_unit": "unknown"}, {"endpoint_type": "Jss", "value": null, "unit": "unknown", "time_value": null, "time_unit": "unknown"}], "ingredients": [{"name": "zi", "concentration_raw": "30.0 g", "concentration_value": 30.0, "concentration_unit": "g", "concentration_basis": "w/w"}, {"name": "ibuprofen", "concentration_raw": "3.0 g", "concentration_value": 3.0, "concentration_unit": "g", "concentration_basis": "w/w"}], "evidence": [{"field": "Q_final", "locator": "PAGE 6", "snippet": "After 6 h of in vitro release, fibers F1, F2 and F3 released 88.3%, 94.7%, and 97.1% of the contained IBU."}], "needs_supp": "no", "confidence": 0.95, "notes": "Cumulative amount released was reported; details on flux and Jss were not explicitly provided."}], "extraction_notes": "Extracted relevant data only from explicitly stated formulations and results. Summary of findings consistent with clinical implications.", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-013-9953-1__81485635ae.pdf"}
{"doi": "10.1098/rsfs.2019.0132", "title": "In vitro and computational modelling of drug delivery across the outer blood–retinal barrier", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "silicone oil", "barrier_category": "both", "barrier_name": "outer blood–retinal barrier (OBRB)", "api_name": "ibuprofen", "api_conc_raw": "1 mg/ml", "api_conc_value": 1.0, "api_conc_unit": "mg/ml", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": null, "time_unit": "hours"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg/h", "time_value": null, "time_unit": "hours"}, {"endpoint_type": "Jss", "value": null, "unit": "mg/h/cm²", "time_value": null, "time_unit": "hours"}], "ingredients": [{"name": "ibuprofen", "concentration_raw": "1 mg/ml", "concentration_value": 1.0, "concentration_unit": "mg/ml", "concentration_basis": "w/w"}, {"name": "silicone oil", "concentration_raw": "1000 cSt", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 3", "snippet": "1 mg ml−1 was dissolved in technical grade 1000 cSt silicone oil."}, {"field": "design", "locator": "PAGE 5", "snippet": "the QV600 system was arranged in a single-pass series fluid circuit using a peristaltic pump."}, {"field": "endpoint", "locator": "PAGE 6", "snippet": "At set time intervals, the ports were clamped shut and the volume of PBS beneath the ibu-SiO removed."}], "needs_supp": "no", "confidence": 0.85, "notes": "Main endpoint value is not explicitly stated and is determined through figures; details on flux and Jss are missing."}], "extraction_notes": "Extracted data focuses on ibuprofen within the context of the specified study conditions. Endpoint values derived from the text but are not strictly numeric.", "pdf_path": "GenAI\\papers\\pdf\\10.1098_rsfs.2019.0132__2fa2660da2.pdf"}
{"doi": "10.18433/j3160b", "title": "A new vesicle-loaded hydrogel system suitable for topical applications: preparation and characterization.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "hydrogel", "barrier_category": "skin", "barrier_name": "stratum corneum", "api_name": "ibuprofen", "api_conc_raw": "1%", "api_conc_value": null, "api_conc_unit": "w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 48.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen (IBU)", "concentration_raw": "1%", "concentration_value": null, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "Locust Bean Gum (LBG)", "concentration_raw": "0.5%", "concentration_value": null, "concentration_unit": "w/V", "concentration_basis": "w/v"}, {"name": "Xanthan", "concentration_raw": "0.5%", "concentration_value": null, "concentration_unit": "w/V", "concentration_basis": "w/v"}, {"name": "Tween 20 (Polysorbate 20)", "concentration_raw": "1:1 molar ratio with cholesterol", "concentration_value": null, "concentration_unit": "", "concentration_basis": "other"}], "evidence": [{"field": "Q_final", "locator": "PAGE 3", "snippet": "...and only about 60% of the loaded drug was capable to diffuse from the matrix."}, {"field": "formulation", "locator": "PAGE 1", "snippet": "...a new formulation consisting of non ionic surfactant vesicular structures, niosomes (NSVs), loaded with model molecules..."}], "needs_supp": "no", "confidence": 0.8, "notes": "Main endpoint value for cumulative amount permeated/released (Q_final) is not explicitly numerical in the text; see release figures."}], "extraction_notes": "Single distinct formulation identified; no need for multiple records.", "pdf_path": "GenAI\\papers\\pdf\\10.18433_j3160b__e18921d9f7.pdf"}
{"doi": "10.3797/scipharm.1204-14", "title": "Synthesis, characterization, and in vitro evaluation of new Ibuprofen polymeric prodrugs based on 2-hydroxypropyl methacrylate.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "polymeric prodrug", "barrier_category": "both", "barrier_name": "hydrolytic conditions", "api_name": "ibuprofen", "api_conc_raw": "18-21 wt. %", "api_conc_value": null, "api_conc_unit": "wt. %", "api_conc_basis": "uncertain", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": null, "time_unit": "hours"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "contains 18-21 wt. %", "concentration_value": null, "concentration_unit": "wt. %", "concentration_basis": "uncertain"}, {"name": "2-Hydroxypropyl methacrylate", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "uncertain", "concentration_basis": "uncertain"}, {"name": "2-Hydroxyethyl methacrylate", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "uncertain", "concentration_basis": "uncertain"}, {"name": "Methyl methacrylate", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "uncertain", "concentration_basis": "uncertain"}], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 11", "snippet": "the drug content of the copolymers showed that this method permits the incorporation of 18–21 wt. % of ibuprofen into copolymer structures."}, {"field": "Q_final", "locator": "PAGE 14", "snippet": "the present investigation can be used in the prolongation of transit time and are useful as drug carriers for the development of pH-sensitive polymeric prodrugs."}], "needs_supp": "yes", "confidence": 0.8, "notes": "Endpoint_main value set to null due to lack of explicit numeric release data. Concentrations of ingredients are uncertain as no specific numeric values were provided."}], "extraction_notes": "Only one distinct formulation with ibuprofen was explicitly defined, thus only one record is extracted.", "pdf_path": "GenAI\\papers\\pdf\\10.3797_scipharm.1204-14__6d2c010d2d.pdf"}
{"doi": "10.3390/nano11071850", "title": "pH-Responsive Chitosan/Alginate Polyelectrolyte Complexes on Electrospun PLGA Nanofibers for Controlled Drug Release.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "polymer mesh", "barrier_category": "both", "barrier_name": "CHIT/ALG Coated PLGA Fibers", "api_name": "ibuprofen", "api_conc_raw": "0.021 mg·mL−1", "api_conc_value": null, "api_conc_unit": "mg/mL", "api_conc_basis": "uncertain", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 72.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Chitosan", "concentration_raw": "medium molecular weight, 190–310 kDa", "concentration_value": null, "concentration_unit": "kDa", "concentration_basis": "uncertain"}, {"name": "Alginate", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}, {"name": "Ibuprofen", "concentration_raw": "sat. sol. in pH 2.0", "concentration_value": null, "concentration_unit": "mg/mL", "concentration_basis": "uncertain"}], "evidence": [{"field": "Q_final", "locator": "PAGE 12", "snippet": "The release of IBU from the meshes was measured in PBS at pH 7.4 and pH 5.5 as well as in SGF (pH 1.0). The release is depicted by a strong burst release, where most of the drug was released over 5 h, followed by a more sustained release over a 3-day time span."}, {"field": "ibuprofen_concentration", "locator": "PAGE 9", "snippet": "To study the kinetics of the loading from the electrospun constructs in response to pH, IBU was used as a model drug. For loading the drug, the meshes were immersed in a saturated solution of IBU in MilliQ water (0.021 mg·mL−1) at pH 2.0, 5.0, 7.0, and 10.0."}], "needs_supp": "yes", "confidence": 0.8, "notes": "Main endpoint values are only described in the text without specific numerical values. Some ingredients and formulations are not specifically quantified, leading to uncertainty."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.3390_nano11071850__a1c10dc1dc.pdf"}
{"doi": "10.3390/pharmaceutics16081055", "title": "Mixed Micellar Gel of Poloxamer Mixture for Improved Solubilization of Poorly Water-Soluble Ibuprofen and Use as Thermosensitive In Situ Gel.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "gel", "barrier_category": "uncertain", "barrier_name": "uncertain", "api_name": "ibuprofen", "api_conc_raw": "1.0 mg/mL", "api_conc_value": 1.0, "api_conc_unit": "mg/mL", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 84.0, "unit": "%", "time_value": 48.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Poloxamer 403 (P403)", "concentration_raw": "19% w/v", "concentration_value": 19.0, "concentration_unit": "% w/v", "concentration_basis": "w/v"}, {"name": "Poloxamer 407 (P407)", "concentration_raw": "19% w/v", "concentration_value": 19.0, "concentration_unit": "% w/v", "concentration_basis": "w/v"}], "evidence": [{"field": "api_concentration", "locator": "PAGE 3", "snippet": "Ibuprofen, a poorly water-soluble drug, has an aqueous solubility of around 0.232 mM (0.048 mg/mL) at 25 ◦C and 0.324 mM (0.067 mg/mL) at 30 ◦C."}, {"field": "Q_final", "locator": "PAGE 16", "snippet": "all gel depots sustained the release of the drug molecules for 48 h... resulting in mean cumulative releases of approximately 84, 71, and 66% for 19% 0.75P403-0.25P407 with 1.0 mg/mL, 1.4 mg/mL, and 1.8 mg/mL of ibuprofen, respectively."}], "needs_supp": "no", "confidence": 0.9, "notes": "Only one formulation of ibuprofen was clearly defined."}], "extraction_notes": "Information was explicitly provided in the text. The endpoint values were directly stated.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_pharmaceutics16081055__065e618dc2.pdf"}
{"doi": "10.1007/s11095-024-03747-6", "title": "Fluorinated PAMAM-Arginine Carrier Prodrugs for pH-Sensitive Sustained Ibuprofen Delivery", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "not specified", "barrier_category": "both", "barrier_name": "pH-sensitive barrier", "api_name": "ibuprofen", "api_conc_raw": "10 mg/g", "api_conc_value": 10.0, "api_conc_unit": "mg/g", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 80.0, "unit": "%", "time_value": 72.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": ")", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": ")", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "fluorinated PAMAM", "concentration_raw": "10 mg/g", "concentration_value": 10.0, "concentration_unit": "mg/g", "concentration_basis": "w/w"}], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 4", "snippet": "a concentration of 10 mg/g (drug/polymer) was considered"}, {"field": "Q_final", "locator": "PAGE 10", "snippet": "an almost complete release of IBU (close to 80%) was achieved for both 1 and 2 at pH = 8 after 72 h"}], "needs_supp": "yes", "confidence": 0.9, "notes": "Endpoint optional set to null due to lack of explicit numeric values reported for flux and Jss."}], "extraction_notes": "Extracted data from the text in the provided pages with explicit formulations and conditions. The endpoint main value is reported based on provided information; details regarding flux and Jss were not explicitly stated, hence marked as null.", "pdf_path": "GenAI\\papers\\pdf\\10.1007_s11095-024-03747-6__42a2bcfb6b.pdf"}
{"doi": "10.1097/opx.0000000000000849", "title": "Controlled Release of Multiple Therapeutics from Silicone Hydrogel Contact Lenses", "records": [{"study_type": "IVPT", "cell_type": "diffusion_cell_unspecified", "dosage_form": "silicone hydrogel contact lenses", "barrier_category": "both", "barrier_name": "silicone hydrogel", "api_name": "ibuprofen", "api_conc_raw": "150 μg/lens", "api_conc_value": 150.0, "api_conc_unit": "μg/lens", "api_conc_basis": "other", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "μg", "time_value": null, "time_unit": "days"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "μg/mm²/hr", "time_value": null, "time_unit": "days"}, {"endpoint_type": "Jss", "value": null, "unit": "μg/mm²/hr", "time_value": null, "time_unit": "days"}], "ingredients": [{"name": "HPMC", "concentration_raw": "500 μg/lens", "concentration_value": 500.0, "concentration_unit": "μg/lens", "concentration_basis": "other"}, {"name": "trehalose", "concentration_raw": "500 μg/lens", "concentration_value": 500.0, "concentration_unit": "μg/lens", "concentration_basis": "other"}, {"name": "prednisolone", "concentration_raw": "150 μg/lens", "concentration_value": 150.0, "concentration_unit": "μg/lens", "concentration_basis": "other"}], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 8", "snippet": "...considering loading amounts of each drug at 150μg per lens, approximately 45 μg are released in one day."}, {"field": "Q_final", "locator": "PAGE 8", "snippet": "...Due to their hydrophobic nature and interactions, they take more time than trehalose to transport from the lens…"}], "needs_supp": "yes", "confidence": 0.85, "notes": "Main endpoint values are inferred from figures with no specified numeric values in the table."}], "extraction_notes": "Focused on the release of ibuprofen from silicone hydrogel lenses; numeric values were not directly provided for endpoints; hence, main endpoint value is set to null.", "pdf_path": "GenAI\\papers\\pdf\\10.1097_opx.0000000000000849__43748dc834.pdf"}
{"doi": "10.1016/j.jsps.2017.03.004", "title": "Vapour-phase method in the synthesis of polymer-ibuprofen sodium-silica gel composites", "records": [{"study_type": "both", "cell_type": "Franz", "dosage_form": "not specified", "barrier_category": "uncertain", "barrier_name": "not specified", "api_name": "ibuprofen", "api_conc_raw": "35 mg/1 ml EtOH", "api_conc_value": 35.0, "api_conc_unit": "mg/mL", "api_conc_basis": "uncertain", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": null, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg/h/cm²", "time_value": null, "time_unit": "h"}, {"endpoint_type": "Jss", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": "h"}], "ingredients": [{"name": "ibuprofen sodium", "concentration_raw": "35 mg per portion", "concentration_value": 35.0, "concentration_unit": "mg", "concentration_basis": "uncertain"}, {"name": "poly(TRIM)", "concentration_raw": "~53 mg/g", "concentration_value": 53.0, "concentration_unit": "mg/g", "concentration_basis": "w/w"}, {"name": "poly(HEMA-co-TRIM)", "concentration_raw": "~62 mg/g", "concentration_value": 62.0, "concentration_unit": "mg/g", "concentration_basis": "w/w"}], "evidence": [{"field": "ibuprofen_concentration", "locator": "PAGE 2", "snippet": "the amount of drug was the same and equaled at about 7 mg per portion."}, {"field": "endpoint", "locator": "PAGE 5", "snippet": "At this juncture, the vapour mixtures of water and hydrochloric acid (A) or water and ammonia (B)..."}, {"field": "endpoint", "locator": "PAGE 5", "snippet": "the actual contents of silica gel within composites, it should be taken into account, that residues are also obtained after..."}, {"field": "study_type", "locator": "PAGE 3", "snippet": "The release of ibuprofen sodium from composites demonstrate that there are differences in the rate and efficiency of drug desorption from them."}, {"field": "evidence", "locator": "PAGE 4", "snippet": "the introduction of silica gel into both solid dispersions only marginally affects the shape of N2 isotherms."}], "needs_supp": "uncertain", "confidence": 0.8, "notes": "Q_final and other endpoints are not numerically specified in the text; they might be in figures not provided."}], "extraction_notes": "Structured data has been extracted based on the explicit formulations and conditions related to ibuprofen found in the provided text.", "pdf_path": "GenAI\\papers\\pdf\\10.1016_j.jsps.2017.03.004__e3d1f0291a.pdf"}
{"doi": "10.1208/s12249-015-0474-y", "title": "Regulating the Skin Permeation Rate of Escitalopram by Ion-pair Formation with Organic Acids.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "ion-pair complex", "barrier_category": "skin", "barrier_name": "rabbit abdominal skin", "api_name": "ibuprofen", "api_conc_raw": "N/A", "api_conc_value": null, "api_conc_unit": "N/A", "api_conc_basis": "uncertain", "endpoint_main": {"endpoint_type": "Q_final", "value": 995.13, "unit": "μg/cm2", "time_value": 8.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 113.09, "unit": "μg/(cm2 h)", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Escitalopram", "concentration_raw": "N/A", "concentration_value": null, "concentration_unit": "N/A", "concentration_basis": "uncertain"}, {"name": "Isopropyl Palmitate", "concentration_raw": "N/A", "concentration_value": null, "concentration_unit": "N/A", "concentration_basis": "uncertain"}, {"name": "Ibuprofen", "concentration_raw": "N/A", "concentration_value": null, "concentration_unit": "N/A", "concentration_basis": "uncertain"}], "evidence": [{"field": "Q_final", "locator": "PAGE 6", "snippet": "ESP-IB 995.13 ± 144.19"}, {"field": "flux", "locator": "PAGE 6", "snippet": "J = 113.09 ± 20.65"}], "needs_supp": "no", "confidence": 0.85, "notes": "Only one formulation was clearly defined in the text."}], "extraction_notes": "Info extracted based on available text and metrics stated; supplementary details were insufficient for definite clarification beyond basic formulation.", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-015-0474-y__b08f9feea7.pdf"}
{"doi": "10.3390/gels10110704", "title": "Decellularized Macroalgae as Complex Hydrophilic Structures for Skin Tissue Engineering and Drug Delivery", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "hydrogel", "barrier_category": "both", "barrier_name": "decellularized macroalgae", "api_name": "ibuprofen", "api_conc_raw": "71 ± 2 µg/mg (green algae - SDS)", "api_conc_value": 71.0, "api_conc_unit": "µg/mg", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "µg", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "µg/h·cm²", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "µg/h·cm²", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "10% (wt:wt)", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}], "evidence": [{"field": "Q_final", "locator": "PAGE 11", "snippet": "the cumulative release was plotted versus time, and the kinetic curves are depicted in Figure 3."}, {"field": "Ibuprofen_concentration", "locator": "PAGE 6", "snippet": "71 ± 2 µg/mg for green algae—SDS."}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint values are referenced without numeric specification; assumed to be in figures."}], "extraction_notes": "All extracted data reflects the values explicitly stated in the provided text.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_gels10110704__b52d02c892.pdf"}
